...
首页> 外文期刊>Assay and drug development technologies >An arrayed RNA interference genome-wide screen identifies candidate genes involved in the MicroRNA 21 biogenesis pathway
【24h】

An arrayed RNA interference genome-wide screen identifies candidate genes involved in the MicroRNA 21 biogenesis pathway

机译:阵列式RNA干扰全基因组筛选可确定参与MicroRNA 21生物发生途径的候选基因

获取原文
获取原文并翻译 | 示例

摘要

MicroRNAs (miRNAs) are evolutionary conserved noncoding molecules that regulate gene expression. They influence a number of diverse biological functions, such as development and differentiation. However, their dysregulation has been shown to be associated with disease states, such as cancer. Genes and pathways regulating their biogenesis remain unknown and are highly sought after. For this purpose, we have validated a multiplexed high-content assay strategy to screen for such modulators. Here, we describe its implementation that makes use of a cell-based gain-of-function reporter assay monitoring enhanced green fluorescent protein expression under the control of miRNA 21 (miR-21); combined with measures of both cell metabolic activities through the use of Alamar Blue and cell death through imaged Hoechst-stained nuclei. The strategy was validated using a panel of known genes and enabled us to successfully progress to and complete an arrayed genome-wide short interfering RNA (siRNA) screen against the Ambion Silencer Select v4.0 library containing 64,755 siRNA duplexes covering 21,565 genes. We applied a high-stringency hit analysis method, referred to as the Bhinder-Djaballah analysis method, leading to the nomination of 1,273 genes as candidate inhibitors of the miR-21 biogenesis pathway; after several iterations eliminating those genes with only one active duplex and those enriched in seed sequence mediated off-target effects. Biological classifications revealed four major control junctions among them vesicular transport via clathrin-mediated endocytosis. Altogether, our screen has uncovered a number of novel candidate regulators that are potentially good druggable targets allowing for the discovery and development of small molecules for regulating miRNA function.
机译:微小RNA(miRNA)是调节基因表达的进化保守非编码分子。它们影响许多不同的生物学功能,例如发育和分化。然而,已经表明它们的失调与疾病状态如癌症有关。调节其生物发生的基因和途径仍然是未知的,并受到高度追捧。为此,我们已经验证了筛选这种调节剂的多重高含量检测策略。在这里,我们描述了其实现,该实现利用了基于细胞的功能获得报告基因测定法,该测定法监测了在miRNA 21(miR-21)控制下增强的绿色荧光蛋白表达;通过使用Alamar Blue结合两种细胞代谢活动的测量值以及通过成像的Hoechst染色核的细胞死亡测量值。该策略已使用一组已知基因进行了验证,使我们能够成功完成针对Ambion Silencer Select v4.0文库的阵列全基因组短干扰RNA(siRNA)筛选,该文库包含64,755个覆盖21,565个基因的siRNA双链体。我们应用了一种高度严格的命中分析方法,称为Bhinder-Djaballah分析方法,从而导致1,273个基因被提名为miR-21生物发生途径的候选抑制剂。经过几次迭代,消除了那些只有一个活性双链体的基因,以及那些富含种子序列的基因介导的脱靶效应。生物学分类揭示了通过网格蛋白介导的内吞作用的四个主要控制连接点在它们之间的囊泡运输。总而言之,我们的筛选发现了许多新颖的候选调节因子,这些潜在的潜在调节剂可能是良好的药物靶向,可以发现和开发用于调节miRNA功能的小分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号